The School of Public Health and Community Medicine, University of New South Wales, NSW 2052, Australia.
The School of Public Health and Community Medicine, University of New South Wales, NSW 2052, Australia.
Vaccine. 2018 Sep 18;36(39):5910-5915. doi: 10.1016/j.vaccine.2018.08.007. Epub 2018 Aug 23.
There is growing evidence that there is within (intra-) season waning of influenza vaccine protection in older adults, suggesting there may be a benefit to giving influenza vaccine closer to the time of increased infection risk. We aimed to quantitatively evaluate the impact of modifying the timing of influenza vaccination in U.S. older adults.
Using historical data (2010/2011-2015/2016, inclusive) on influenza activity and vaccine uptake, we explore the optimal time to begin vaccinating older adults (≥65 years) in the U.S. to maximize prevention of influenza. We modelled the effect of changing the timing of vaccination by estimating the percentage change to the current disease burden and used this to calculate the estimated optimal week to begin vaccination in the U.S.
When we assumed a relatively slower waning protection rate (over 52 weeks), the estimated optimal time to begin vaccinating those aged ≥65 years varied between mid-August (week 34, 2012-2013) and mid-late October (week 43, 2011-2012) depending on the season, resulting in 0.44% and 5.11% of the current disease burden prevented respectively. Under faster waning (over 26 weeks), the estimated optimal week varied between early September (week 37, 2012-2013) and mid-November (week 47, 2011-2012), resulting in 3.69% and 11.97% of the current disease burden prevented respectively.
While it is difficult to determine the ideal time to start to vaccinate due to substantial variation in timing of individual seasons, we found that there are potentially substantial benefits to minimizing the time between vaccination and influenza activity in U.S. older adults. Modest delays in immunization were beneficial in the seasons we evaluated. If further evidence suggests fast waning, longer delays may be warrant as in these scenarios the timing of the current vaccination was often very suboptimal.
越来越多的证据表明,老年人的流感疫苗保护作用会随时间推移而减弱(即“季节内衰减”),这表明在感染风险增加时接种流感疫苗可能会带来益处。我们旨在定量评估修改美国老年人接种流感疫苗时间的影响。
利用流感活动和疫苗接种的历史数据(2010/2011 年至 2015/2016 年,包含在内),我们探讨了美国老年人开始接种流感疫苗的最佳时间,以最大限度地预防流感。我们通过估计当前疾病负担的百分比变化来模拟改变接种时间的效果,并利用这一结果计算出美国开始接种的最佳周数。
当我们假设保护作用衰减相对较慢(超过 52 周)时,估计≥65 岁人群开始接种的最佳时间因季节而异,在 2012-2013 年的第 34 周(8 月中旬)至 2011-2012 年的第 43 周(10 月中下旬)之间变化,分别可预防当前疾病负担的 0.44%和 5.11%。在保护作用衰减较快(26 周以内)的情况下,估计的最佳周数在 2012-2013 年的第 37 周(9 月初)至 2011-2012 年的第 47 周(11 月中旬)之间变化,分别可预防当前疾病负担的 3.69%和 11.97%。
由于各季节的起始时间存在较大差异,因此难以确定开始接种的理想时间,但我们发现,在美国老年人中,尽可能缩短疫苗接种与流感活动之间的时间间隔可能会带来显著的益处。我们评估的季节中,适度推迟免疫接种是有益的。如果有进一步的证据表明衰减速度较快,则可能需要更长的时间延迟,因为在这些情况下,当前疫苗接种的时间通常非常不理想。